Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Gynecologic Oncology|March 27, 2019
Molecular markers in recurrent stage I, grade 1 endometrioid endometrial cancersMarisa R Moroney, Kurtis D Davies, Adam C Wilberger, et al.
Gynecologic Oncology|June 22, 2014
A phase II trial of a surgical protocol to decrease the incidence of wound complications in obese gynecologic oncology patientsAkiva P Novetsky, Israel Zighelboim, Saketh R Guntupalli, et al.
American Journal of Clinical Oncology|June 10, 2016
Perioperative Mortality in Nonelderly Adult Patients With Cancer: A Population-based Study Evaluating Health Care Disparities in the United States According to Insurance StatusArya Amini, Norman Yeh, Bernard L Jones, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|November 3, 2023
Prospective Clinical Prognostication of Endometrial Carcinomas Based on Next-Generation Sequencing and Immunohistochemistry-Real-World Implementation and Results at a Tertiary Care CenterKurtis D Davies, Lynelle P Smith, Amy Guimaraes-Young, et al.
JAMA Network Open|June 27, 2020
Safety and Efficacy of Apixaban vs Enoxaparin for Preventing Postoperative Venous Thromboembolism in Women Undergoing Surgery for Gynecologic Malignant Neoplasm: A Randomized Clinical TrialSaketh R Guntupalli, Alyse Brennecke, Kian Behbakht, et al.
Gynecologic Oncology|July 23, 2025
A phase II, randomized, double-blind study of the use of rucaparib vs. placebo maintenance therapy in metastatic and recurrent endometrial cancerBradley R Corr, Ashley Haggerty, Stefan M Gysler, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|September 27, 2023
Cancer and the risk of perioperative arterial ischaemic eventsBabak B Navi, Cenai Zhang, Jed H Kaiser, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
Combinatory EHMT and PARP inhibition induces an interferon response and a CD8 T cell-dependent tumor regression in PARP inhibitor-resistant modelsLily L Nguyen, Zachary L Watson, Raquel Ortega, et al.
Molecular Cancer Therapeutics|May 7, 2024
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune ActivationLily L Nguyen, Zachary L Watson, Raquel Ortega, et al.
Molecular Cancer Therapeutics|June 12, 2024
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune ActivationLily L Nguyen, Zachary L Watson, Raquel Ortega, et al.
Pageof 7